Education
About Us
Working with TipRanks
Follow Us
Jonathan Goldman Insider Profile
4 Followers
Jonathan Goldman, Director at Avalo Therapeutics, holds 0.00 shares in Avalo Therapeutics (Ticker: AVTX).
Jonathan Goldman has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Jonathan Goldman does not currently own shares as a corporate insider.
A breakdown of Jonathan Goldman's holdings
Insider Roles
Director
Roles that Jonathan Goldman holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Jonathan Goldman
Jonathan Goldman's Trading History
List of latest transactions for each holding click on a transaction to see Jonathan Goldman's performance on stock
You May Also Like
Jonathan Goldman insider profile FAQ
What is the percentage of profitable transactions made by Jonathan Goldman?
The percentage of profitable transactions made by Jonathan Goldman is ―.
What is the average return per transaction made by Jonathan Goldman?
The average return per transaction made by Jonathan Goldman is ―.
What stocks does Jonathan Goldman hold?
Jonathan Goldman holds: AVTX stocks.
What was Jonathan Goldman’s latest transaction?
Jonathan Goldman latest transaction was an Uninformative Buy of $81.02K.
What was Jonathan Goldman's most profitable transaction?
Jonathan Goldman’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Jonathan Goldman's role in Avalo Therapeutics?
Jonathan Goldman's role in Avalo Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.